Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Hepatology
1008-1704
2011 Issue 3
hbv ji yin xing yu ti bi fu ding liao xiao de guan xi
li wei ; li ying
..............page:233-235
la mi fu ding lian he ku can su zhi liao man xing yi xing gan yan de xi tong ping jia he meta fen xi
liu li ; huang han ling ; mu jing ping ; zhao lei
..............page:228-233
bu tong bing yin zhi gan zu zhi yan zheng huai si he xian wei hua cheng du de bi jiao
wang ya qing ; shen hong hui ; xu zhi qiang ; xu wei ; wang xiao peng ; bai bing zuo
..............page:235-237
Progress in the treatment of autoimmune hepatitis (AIH)
TANG Wen;JIA Ji-dong
..............page:249-252
Experts consensus on the norms of local ablation therapy for hepatocellular carcinoma
chen min shan ; chen min hua
..............page:242-244
Experts consensus on pathological diagnosis of primary liver cancer
cong wen ming ; hu xi zuo ; sun yun tian ; tan yun shan ; ji xiao long ; yun jing ping ; zhu hong guang ; guo hui ; wang rui an ; liu su xiang ; yin hong lin ; wang zuo ; li zeng shan ; ji yuan
..............page:244-246
jin long jiao nang dui ren gan ai gao zhuan yi xi bao xi zhuan yi de yi zhi zuo yong
li li xin ; ye sheng long ; wang yan hong ; li jian sheng ; sun rui xia ; xue qiong ; chen jie ; gao dong mei ; zhao yan
..............page:240-241
Effect of TACE on cellular immune function and Treg in patients with primary liver cancer (PLC)
LIAO Juan;WANG Chun-hui;LI Xiao;MENG Wen-tong
..............page:198-201
The dysfunction of mitochondria and nonalcoholic fatty liver disease(NAFLD)
CAO Wei;ZHAO Cai-yan
..............page:256-259
Effects of Kezhi capsule on oxidative stress in mice with non-alcoholic steatohepatitis
WANG Rong-qi;NAN Yue-mia;ZHAO Su-xian;MI Hong-mei;KONG Ling-bo;JIA Yan-hong
..............page:216-219
103 li ji xing yi xing gan yan huan zhe lin chuang te zheng ji zhuan gui fen xi
yang guo ya ; chen ke ; wang zuo ; xie qing ; xie jing dong ; zhuang yan ; gui hong lian ; shi dong mei
..............page:220-221
gan dou zhuang he bian xing gan yi zhi shu hou bing fa tuo sui qiao ji bing 1 li
chen jian bin ; chen guo yong ; sun jian jun ; li cai li
..............page:276
jia zhuang xian gong neng kang jin zheng he bing yan zhong gan gong neng sun hai 1 li
xu xiu liang ; zuo da yu ; jin jia lin
..............page:277
kong zhi bu ye liang dui zhi liao gan ying hua jing mai qu zhang po lie chu xue de lin chuang guan cha
tang zuo ; xiang pei ; xu wei ; qiu quan xing ; hu xue jun ; fu yu zhang ; yao ping
..............page:267-268
Expression of XIAP in HCC and its influence in HCC recurrence
guo xiao dong ; qu jian hui ; xiong zuo ; sun zhi qiang ; liu shu hong ; zhao yu lai ; zhou guang de ; zhao jing min
..............page:206-208
bchao ct jian cha zai yuan fa xing gan ai shou zhen zhong de zuo yong
zhao chun hua ; chen wei hua ; zhou wen feng ; zhang chun mei ; xi zuo
..............page:269-271
Treatment with nucleotide analogues on children with chronic hepatitis B
YU Hai-ying;CAO Xing-guo
..............page:264-265
Nonalcoholic fatty liver disease(NAFLD) and Toll-like receptor 4
LI Nan;XU Zheng-jie;FAN Jian-gao
..............page:259-261
Prognostic evaluation of cirrhosis
XUE Zeng-xi;FU Qin-chun
..............page:253-256
46 li yao wu xing gan bing lin chuang yong yao liao xiao guan cha
chen jin wu ; chen qi kui ; yuan yu hong ; yu tao
..............page:266-267
The relationship between fatty liver and hyperuricemia
HU Chen-bo;SHI Jun-ping
..............page:202-205
Ten-year follow-up of serum AFP for 395 liver disease patients
GU Sheng-wang;ZHAO Bing;SUN Yao-yao;JIANG Zhao-rong;WANG Jian-guo
..............page:213-215
The efficacy of human umbilical cord mesenchymal stem cells transplantation in patients with decompensated cirrhosis after hepatitis
BYU Hong;WANG Gen-yin;SUN Dian-xing;KANG Fu-biao;LI Hai-jun;YANG Xin-ying;WANG Yu-wen;ZHANG Jun;ZHANG Yong
..............page:185-189
Clinical research of liver cirrhosis promoted by intestinal endotoxemia
LV Zhen;ZHANG You-xiang
..............page:262-263
s- xian zuo dan an suan dui gan yi zhi shu hou zao qi gan gong neng bao hu ji cu jin dan zhi fen mi de zuo yong
li dong liang ; jiang yi ; cai qiu cheng ; lv li zhi ; xie hai ying
..............page:226-227
The evaluation of liver fibrosis based on serum protein electrophoreses ratio models
ZHANG Zhan-qing;LU Wei;CHEN Shu-qin;WANG Yan-bing;RAO Min;TONG Hai-tao;FENG Yan-ling;ZHOU Yi
..............page:193-197
A retrospective study: comparison of S-adenosyl-L-methionine, ursodeoxycholic acid and their combination in treating intrahepatic cholestasis of pregnancy
CHEN Hui;DENG Dong-rui;QIAO Fu-yuan;CHEN Su-hua;FENG Ling;ZENG Wan-jiang;LI Mao-qin;DUAN Na
..............page:209-212
Clinical syndromes and consequences of antiretroviral-related hepatotoxicity
ZHENG Jian-ming;SHI Guang-feng
..............page:247-249
yi xing gan yan huan zhe dan chun xing dan jian zuo mei ji du jiang di 1 li
ji ying jie ; fan zhen ping ; zhang wen zuo
..............page:189
Clinical analysis of 29 liver cirrhosis patients with portal vein thrombosis
TIAN Feng;WANG Yuan;XIE Ying;ZHANG Ya-jie
..............page:190-192
hcv gan ran bu tong jie duan xue qing mian yi xi bao yin zi shui ping de dong tai bian hua
zhang lin ; chen wei ; zhang dan ; wu dan ; zuo xiao guang
..............page:224-225